{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:09:39Z","timestamp":1791443379756,"version":"4.3.3"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["64940"],"award-info":[{"award-number":["64940"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["65103"],"award-info":[{"award-number":["65103"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107158","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T10:42:35Z","timestamp":1605004955000},"page":"107158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Oncostatin M: A mysterious cytokine in cancers"],"prefix":"10.1016","volume":"90","author":[{"given":"Ali","family":"Masjedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Hajizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Beigi Dargani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Beyzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Aksoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Zekiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107158_b0005","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.33114","article-title":"Profiling global cancer incidence and mortality by socioeconomic development","author":"Lortet-Tieulent","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107158_b0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.107158_b0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.actbio.2019.09.009","article-title":"Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: a review","volume":"101","author":"Thakkar","year":"2020","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2016.04.009","article-title":"Targeting tumor microenvironment in cancer therapy","volume":"380","author":"Singh","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/jfb6010081","article-title":"Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach","volume":"6","author":"Adjei","year":"2015","journal-title":"J. Funct. Biomater."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2020.107158_b0040","article-title":"Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells","volume":"116952","author":"Hajizadeh","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2020.107158_b0045","doi-asserted-by":"crossref","first-page":"173235","DOI":"10.1016\/j.ejphar.2020.173235","article-title":"Silencing of HIF-1alpha\/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression","volume":"882","author":"Hajizadeh","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107158_b0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharmthera.2016.09.011","article-title":"Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment","volume":"168","author":"Atretkhany","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","article-title":"Tumor microenvironment: sanctuary of the devil","volume":"368","author":"Hui","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107158_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cytogfr.2007.01.015","article-title":"Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape","volume":"18","author":"Salazar-Onfray","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0952-7915(99)00035-7","article-title":"Cytokines that regulate autoimmune responses","volume":"11","author":"Falcone","year":"1999","journal-title":"Curr. Opin. Immunol."},{"issue":"14","key":"10.1016\/j.intimp.2020.107158_b0075","first-page":"2042","article-title":"Oncostatin-M as a novel biomarker in colon cancer patients and its association with clinicopathologic variables","volume":"18","author":"Gurluler","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2020.107158_b0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MPA.0000000000000155","article-title":"Serum cytokine profile in patients with pancreatic cancer","volume":"43","author":"Torres","year":"2014","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1997.8522478.x","article-title":"Serum oncostatin M in multiple myeloma: association with prognostic factors","volume":"96","author":"Koskela","year":"1997","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/path.4305","article-title":"Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma","volume":"232","author":"Caffarel","year":"2014","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.intimp.2020.107158_b0095","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.intimp.2020.107158_b0100","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.biopha.2018.09.177","article-title":"The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer","volume":"108","author":"Masjedi","year":"2018","journal-title":"Biomed. Pharmac = Biomedecine & Pharmacotherapie"},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107158_b0110","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.139.9.2977","article-title":"Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells","volume":"139","author":"Brown","year":"1987","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.intimp.2020.107158_b0115","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1093\/nar\/27.23.4649","article-title":"Cloning and characterization of human oncostatin M promoter","volume":"27","author":"Yongsheng","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2020.107158_b0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10254-003-0013-1","article-title":"Oncostatin M, a multifunctional cytokine","volume":"149","author":"Tanaka","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"23","key":"10.1016\/j.intimp.2020.107158_b0125","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1093\/nar\/27.23.4649","article-title":"Cloning and characterization of human oncostatin M promoter","volume":"27","author":"Ma","year":"1999","journal-title":"Nucl. Acids Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/labinvest.3780220","article-title":"Oncostatin M production by blood and alveolar neutrophils during acute lung injury","volume":"81","author":"Grenier","year":"2001","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/cyto.2002.1023","article-title":"Oncostatin M production by human dendritic cells in response to bacterial products","volume":"17","author":"Suda","year":"2002","journal-title":"Cytokine"},{"issue":"19","key":"10.1016\/j.intimp.2020.107158_b0140","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1158\/0008-5472.CAN-05-1734","article-title":"Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression","volume":"65","author":"Queen","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0145","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.jid.5700136","article-title":"Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds","volume":"126","author":"Goren","year":"2006","journal-title":"J, Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0150","doi-asserted-by":"crossref","first-page":"e116209","DOI":"10.1371\/journal.pone.0116209","article-title":"Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.intimp.2020.107158_b0155","first-page":"2847","article-title":"Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M","volume":"9","author":"Malik","year":"1989","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0160","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1074\/jbc.C100685200","article-title":"MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels","volume":"277","author":"Neininger","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20070311","article-title":"PMA induces stabilization of oncostatin M mRNA in human lymphoma U937 cells","volume":"410","author":"Bandyopadhyay","year":"2008","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0170","first-page":"1882","article-title":"Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M","volume":"10","author":"Linsley","year":"1990","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/cyto.1997.0283","article-title":"Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells","volume":"10","author":"Liu","year":"1998","journal-title":"Cytokine"},{"issue":"51","key":"10.1016\/j.intimp.2020.107158_b0185","doi-asserted-by":"crossref","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","article-title":"Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation","volume":"271","author":"Mosley","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2020.107158_b0190","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0969-2126(00)00176-3","article-title":"Crystal structure and functional dissection of the cytostatic cytokine oncostatin M","volume":"8","author":"Deller","year":"2000","journal-title":"Structure"},{"issue":"18","key":"10.1016\/j.intimp.2020.107158_b0195","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1074\/jbc.RA118.001920","article-title":"The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation","volume":"293","author":"Adrian-Segarra","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0200","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0002-9440(10)64634-2","article-title":"Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo","volume":"157","author":"Langdon","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0205","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1354\/vp.46-1-124","article-title":"Mice overexpressing murine oncostatin M (OSM) exhibit changes in hematopoietic and other organs that are distinct from those of mice overexpressing human OSM or bovine OSM","volume":"46","author":"Juan","year":"2009","journal-title":"Vet. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2020.107158_b0210","doi-asserted-by":"crossref","first-page":"e43155","DOI":"10.1371\/journal.pone.0043155","article-title":"Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor","volume":"7","author":"Drechsler","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cyto.2014.11.007","article-title":"Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis","volume":"72","author":"Ryan","year":"2015","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/path.2361","article-title":"Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas","volume":"215","author":"Chen","year":"2008","journal-title":"J. Pathol."},{"issue":"48","key":"10.1016\/j.intimp.2020.107158_b0225","doi-asserted-by":"crossref","first-page":"36673","DOI":"10.1074\/jbc.M607005200","article-title":"Molecular and functional characterization of a soluble form of oncostatin M\/interleukin-31 shared receptor","volume":"281","author":"Diveu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.intimp.2020.107158_b0230","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1158\/1078-0432.CCR-07-4781","article-title":"Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivo","volume":"14","author":"Brounais","year":"2008","journal-title":"Clin. Cancer Res.: Offic. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0235","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0002-9440(10)62538-2","article-title":"Exclusive neutrophil recruitment with oncostatin M in a human system","volume":"159","author":"Kerfoot","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2020.107158_b0240","first-page":"667","article-title":"ncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene","volume":"8","author":"Liu","year":"1997","journal-title":"OCell Growth Diff.-Publ. Am. Assoc. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0245","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/MCB.15.5.2349","article-title":"Developmental abnormalities in mice transgenic for bovine oncostatin M","volume":"15","author":"Malik","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1359-6101(00)00003-4","article-title":"Role of Oncostatin M in hematopoiesis and liver development","volume":"11","author":"Miyajima","year":"2000","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2020.107158_b0255","doi-asserted-by":"crossref","first-page":"512103","DOI":"10.1155\/2013\/512103","article-title":"The enigmatic cytokine oncostatin m and roles in disease","volume":"2013","author":"Richards","year":"2013","journal-title":"ISRN Inflamm"},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80463-X","article-title":"In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region","volume":"8","author":"Mukouyama","year":"1998","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1532\/IJH97.06090","article-title":"Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow","volume":"84","author":"Minehata","year":"2006","journal-title":"Int. J. Hematol."},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0270","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.mlg.0000187819.89889.4a","article-title":"Upregulation of oncostatin m in allergic rhinitis","volume":"115","author":"Kang","year":"2005","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.intimp.2020.107158_b0275","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/01902140902906412","article-title":"Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction","volume":"35","author":"Simpson","year":"2009","journal-title":"Exp. Lung Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.107158_b0280","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.4049\/jimmunol.181.10.7243","article-title":"Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis","volume":"181","author":"Mozaffarian","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0285","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.1203318","article-title":"Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation","volume":"191","author":"Botelho","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0290","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.4049\/jimmunol.163.12.6651","article-title":"Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130","volume":"163","author":"Hermanns","year":"1999","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0295","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/MCB.17.5.2497","article-title":"Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop","volume":"17","author":"Feng","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2020.107158_b0300","doi-asserted-by":"crossref","unstructured":"L.S. Argetsinger, G.S. Campbell, X. Yang, B.A. Witthuhn, O. Silvennoinen, J.N. Ihle, C. Carter-Su, Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase, 1993.","DOI":"10.1016\/0092-8674(93)90415-M"},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0305","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"issue":"7","key":"10.1016\/j.intimp.2020.107158_b0310","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1074\/jbc.M511779200","article-title":"Three dileucine-like motifs within the interbox1\/2 region of the human oncostatin M receptor prevent efficient surface expression in the absence of an associated Janus kinase","volume":"281","author":"Radtke","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.intimp.2020.107158_b0315","doi-asserted-by":"crossref","first-page":"19465","DOI":"10.1074\/jbc.M710157200","article-title":"Box 2 region of the oncostatin M receptor determines specificity for recruitment of Janus kinases and STAT5 activation","volume":"283","author":"Hintzen","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2020.107158_b0320","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.4049\/jimmunol.176.7.4352","article-title":"Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6","volume":"176","author":"Fritz","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1541-7786.MCR-06-0274","article-title":"Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line","volume":"5","author":"Komyod","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2020.107158_b0330","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.38701","article-title":"Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis","volume":"66","author":"Liu","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.intimp.2020.107158_b0335","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/glia.20694","article-title":"Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes","volume":"56","author":"Baker","year":"2008","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0340","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cellsig.2014.12.016","article-title":"Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1\/2-pathway independent of p38(MAPK)\/MK2","volume":"27","author":"Ehlting","year":"2015","journal-title":"Cell Signal"},{"issue":"13","key":"10.1016\/j.intimp.2020.107158_b0345","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1074\/jbc.M511212200","article-title":"Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism","volume":"281","author":"Stross","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.intimp.2020.107158_b0350","doi-asserted-by":"crossref","first-page":"47038","DOI":"10.1074\/jbc.M107971200","article-title":"Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms","volume":"276","author":"Blanchard","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0355","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.onc.1205100","article-title":"An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells","volume":"21","author":"Grant","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1010614724664","article-title":"Oncostatin M-induced growth inhibition and morphological changes of MDA-MB231 breast cancer cells are abolished by blocking the MEK\/ERK signaling pathway","volume":"66","author":"Li","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0365","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.1471-4159.2001.00202.x","article-title":"Complete inhibition of in vivo glioma growth by oncostatin M","volume":"76","author":"Friedrich","year":"2001","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.intimp.2020.107158_b0370","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1158\/0008-5472.CAN-04-3734","article-title":"Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression","volume":"66","author":"Halfter","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0375","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.onc.1209844","article-title":"Loss of oncostatin M receptor beta in metastatic melanoma cells","volume":"26","author":"Lacreusette","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0380","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.2416","article-title":"Relationship between responsiveness of cancer cells to Oncostatin M and\/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes","volume":"216","author":"Lacreusette","year":"2008","journal-title":"J. Pathol.: J. Pathol. Soc. Great Britain Ireland"},{"issue":"8","key":"10.1016\/j.intimp.2020.107158_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006555","article-title":"Promoter DNA methylation of Oncostatin M receptor-\u03b2 as a novel diagnostic and therapeutic marker in colon cancer","volume":"4","author":"Kim","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0390","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1158\/1078-0432.CCR-08-1778","article-title":"Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs","volume":"15","author":"Deng","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0395","first-page":"1293","article-title":"Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer","volume":"31","author":"Hibi","year":"2011","journal-title":"Anticancer Res."},{"issue":"37","key":"10.1016\/j.intimp.2020.107158_b0400","doi-asserted-by":"crossref","first-page":"60395","DOI":"10.18632\/oncotarget.10939","article-title":"Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.intimp.2020.107158_b0405","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ijc.25776","article-title":"Direct anti-cancer effect of oncostatin M on chondrosarcoma","volume":"128","author":"David","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0410","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7314\/APJCP.2013.14.2.747","article-title":"Inhibition of growth and induction of differentiation of SMMC-7721 human hepatocellular carcinoma cells by Oncostatin M","volume":"14","author":"Kong","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"20","key":"10.1016\/j.intimp.2020.107158_b0415","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1038\/sj.onc.1210950","article-title":"Many roads lead to oncogene-induced senescence","volume":"27","author":"Courtois-Cox","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/15384101.2016.1259037","article-title":"STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence","volume":"16","author":"Bryson","year":"2017","journal-title":"Cell Cycle"},{"issue":"22","key":"10.1016\/j.intimp.2020.107158_b0425","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1158\/0008-5472.CAN-10-3860","article-title":"c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M","volume":"71","author":"Kan","year":"2011","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.intimp.2020.107158_b0430","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/0008-5472.CAN-12-1568","article-title":"Oncostatin M modulates the mesenchymal\u2013epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1600-0609.2000.90167.x","article-title":"Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis","volume":"65","author":"Koskela","year":"2000","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0440","first-page":"495","article-title":"Expression of the IL-6 family cytokines in human brain tumors","volume":"19","author":"Lilja","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09629359990289","article-title":"Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission","volume":"8","author":"Robak","year":"1999","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0450","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/CBM-2012-00276","article-title":"Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73","volume":"11","author":"Liang","year":"2012","journal-title":"Cancer Biomark"},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0455","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1476","article-title":"Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate","volume":"202","author":"Royuela","year":"2004","journal-title":"J. Pathol: A J. Pathol. Soc. Great Britain Ireland"},{"key":"10.1016\/j.intimp.2020.107158_b0460","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28197","article-title":"Overexpression of oncostatin M receptor regulates local immune response in glioblastoma","author":"Guo","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0465","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nn.4295","article-title":"Control of glioblastoma tumorigenesis by feed-forward cytokine signaling","volume":"19","author":"Jahani-Asl","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2020.107158_b0470","first-page":"1","article-title":"Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M","author":"Yu","year":"2019","journal-title":"Gastric Cancer"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107158_b0475","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10428199909083381","article-title":"Interleukin-10 and Gp130 Cytokines in Human Multiple Myeloma","volume":"34","author":"Klein","year":"1999","journal-title":"Leukemia & Lymphoma"},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0480","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/cyto.2002.1022","article-title":"Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas","volume":"17","author":"Savarese","year":"2002","journal-title":"Cytokine"},{"issue":"23","key":"10.1016\/j.intimp.2020.107158_b0485","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1158\/0008-5472.CAN-14-0160","article-title":"Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak\/STAT3 signaling","volume":"74","author":"Lapeire","year":"2014","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107158_b0490","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-015-2342-1","article-title":"Mitogen-activated protein kinase signaling controls basal and oncostatin M-mediated JUNB gene expression","volume":"403","author":"Hicks","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.intimp.2020.107158_b0495","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-13-0238","article-title":"Interleukin-6 and oncostatin-M synergize with the PI3K\/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues","volume":"11","author":"Smith","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"14","key":"10.1016\/j.intimp.2020.107158_b0500","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/onc.2009.488","article-title":"S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer","volume":"29","author":"West","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0505","first-page":"101","article-title":"Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3","volume":"28","author":"Li","year":"2011","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0510","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0898-6568(99)00077-7","article-title":"Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines","volume":"12","author":"Schaefer","year":"2000","journal-title":"Cell. Signal."},{"issue":"2A","key":"10.1016\/j.intimp.2020.107158_b0515","first-page":"1011","article-title":"Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor","volume":"19","author":"Mori","year":"1999","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0520","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ajpath.2012.07.023","article-title":"Oncostatin M is a growth factor for Ewing sarcoma","volume":"181","author":"David","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0525","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ijc.29055","article-title":"Novel function of Oncostatin M as a potent tumour-promoting agent in lung","volume":"136","author":"Lauber","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2020.107158_b0530","article-title":"M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis","author":"Shrivastava","year":"2018","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0535","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/imcb.1035","article-title":"Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo","volume":"96","author":"Dubey","year":"2018","journal-title":"Immunol. Cell Biol."},{"issue":"14","key":"10.1016\/j.intimp.2020.107158_b0540","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.18632\/oncotarget.2110","article-title":"Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin","volume":"5","author":"Tripathi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2020.107158_b0545","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2017.12.017","article-title":"Oncostatin M upregulates HIF-1\u03b1 in breast tumor associated macrophages independent of intracellular oxygen concentration","volume":"194","author":"Shrivastava","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0550","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/sctm.18-0123","article-title":"Concise reviews: cancer stem cell targeted therapies: toward clinical success","volume":"8","author":"Desai","year":"2019","journal-title":"Stem Cells Translat. Med."},{"issue":"28","key":"10.1016\/j.intimp.2020.107158_b0555","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/onc.2017.33","article-title":"Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling","volume":"36","author":"Junk","year":"2017","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0560","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI37480","article-title":"Abrogation of TGF-\u03b2 signaling enhances chemokine production and correlates with prognosis in human breast cancer","volume":"119","author":"Bierie","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0565","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2302\/kjm.65-004-ABST","article-title":"Virus and Host Events in Squamous Carcinogenesis","volume":"65","author":"Coleman","year":"2016","journal-title":"Keio J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0570","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.2016.199","article-title":"Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial\u2013mesenchymal transition and poor overall survival","volume":"115","author":"Kucia-Tran","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0575","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/path.4222","article-title":"Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma","volume":"231","author":"Caffarel","year":"2013","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0580","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1541-7786.MCR-16-0337","article-title":"Potent EMT and CSC phenotypes are induced by oncostatin-M in pancreatic cancer","volume":"15","author":"Smigiel","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0585","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13058-019-1136-x","article-title":"The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer","volume":"21","author":"Doherty","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0590","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neo.2015.01.001","article-title":"Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling","volume":"17","author":"Natesh","year":"2015","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0595","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/onc.2013.105","article-title":"Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer","volume":"33","author":"West","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.intimp.2020.107158_b0600","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/01.ATV.19.8.1835","article-title":"Oncostatin M induces angiogenesis in vitro and in vivo","volume":"19","author":"Vasse","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0605","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3892\/or.2015.3951","article-title":"Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis","volume":"34","author":"Zhu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2020.107158_b0610","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2407-11-125","article-title":"Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines","volume":"11","author":"Fossey","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2020.107158_b0615","unstructured":"H.J. Covert, Oncostatin M Contributes To Breast Tumor Metastasis, 2017."},{"issue":"24","key":"10.1016\/j.intimp.2020.107158_b0620","doi-asserted-by":"crossref","first-page":"18061","DOI":"10.1074\/jbc.M907962199","article-title":"Oncostatin M and transforming growth factor-\u03b21 induce post-translational modification and hyaluronan binding to CD44 in lung-derived epithelial tumor cells","volume":"275","author":"Cichy","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2020.107158_b0625","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cyto.2006.03.004","article-title":"Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells","volume":"33","author":"Jorcyk","year":"2006","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.intimp.2020.107158_b0630","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1172\/JCI91553","article-title":"JAK2-binding long noncoding RNA promotes breast cancer brain metastasis","volume":"127","author":"Wang","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.intimp.2020.107158_b0635","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.18632\/oncotarget.26699","article-title":"HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1\u03b2","volume":"10","author":"Tawara","year":"2019","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tranon.2018.10.004","article-title":"Co-expression of VEGF and IL-6 family cytokines is associated with decreased survival in HER2 negative breast cancer patients: subtype-specific IL-6 family cytokine-mediated VEGF secretion","volume":"12","author":"Tawara","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.intimp.2020.107158_b0645","article-title":"miR-181b\/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation","author":"Han","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0650","doi-asserted-by":"crossref","first-page":"e0192009","DOI":"10.1371\/journal.pone.0192009","article-title":"Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M","volume":"13","author":"Chuerduangphui","year":"2018","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0655","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/ERC-11-0326","article-title":"Oncostatin M suppresses oestrogen receptor-a expression and is associated with poor outcome in human breast cancer","volume":"19","author":"West","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2020.107158_b0660","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrc2713","article-title":"Biological determinants of endocrine resistance in breast cancer","volume":"9","author":"Musgrove","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0665","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.20235","article-title":"Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"64","author":"Godoy-Tundidor","year":"2005","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.intimp.2020.107158_b0670","first-page":"677","article-title":"The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M","volume":"10","author":"Liu","year":"1999","journal-title":"Cell Growth Differ."},{"issue":"3","key":"10.1016\/j.intimp.2020.107158_b0675","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.5010","article-title":"Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma","volume":"244","author":"Kucia-Tran","year":"2018","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107158_b0680","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-17-0148","article-title":"JAK1\/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non\u2013small cell lung cancer","volume":"16","author":"Shien","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"45","key":"10.1016\/j.intimp.2020.107158_b0685","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1038\/onc.2012.573","article-title":"Stat3-coordinated Lin-28\u2013let-7\u2013HMGA2 and miR-200\u2013ZEB1 circuits initiate and maintain oncostatin M-driven epithelial\u2013mesenchymal transition","volume":"32","author":"Guo","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.intimp.2020.107158_b0690","first-page":"1798","article-title":"Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133+ HepG2 liver cancer cells","volume":"17","author":"Fu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.intimp.2020.107158_b0695","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1158\/0008-5472.CAN-09-4210","article-title":"Oncostatin m renders epithelial cell adhesion molecule\u2013positive liver cancer stem cells sensitive to 5-fluorouracil by inducing hepatocytic differentiation","volume":"70","author":"Yamashita","year":"2010","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.intimp.2020.107158_b0700","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1203480","article-title":"Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice","volume":"19","author":"Levy","year":"2000","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2020.107158_b0705","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.1471-4159.2001.00202.x","article-title":"Complete inhibition of in vivo glioma growth by oncostatin M","volume":"76","author":"Friedrich","year":"2001","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0710","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2018.03.056","article-title":"Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3)","volume":"498","author":"Sterbova","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2020.107158_b0715","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.biocel.2013.05.027","article-title":"Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI","volume":"45","author":"Lee","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107158_b0720","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.leu.2401371","article-title":"Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines","volume":"13","author":"Drexler","year":"1999","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.intimp.2020.107158_b0725","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13058-018-0971-5","article-title":"OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung","volume":"20","author":"Tawara","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.107158_b0730","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-17-0148","article-title":"JAK1\/STAT3 Activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer","volume":"16","author":"Shien","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107158_b0735","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-2478(02)00022-6","article-title":"Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells","volume":"82","author":"Holub","year":"2002","journal-title":"Immunol. Lett."},{"issue":"11","key":"10.1016\/j.intimp.2020.107158_b0740","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.4049\/jimmunol.159.11.5648","article-title":"Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells","volume":"159","author":"Cichy","year":"1997","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:29:02Z","timestamp":1744936142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":148,"alternative-id":["S1567576920336250"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107158","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncostatin M: A mysterious cytokine in cancers","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107158"}}